Actelion files motion to dismis antitrust lawsuit over delayed generic version of Tracleer
MLex Summary: Actelion Pharmaceuticals filed a motion to dismiss an antitrust lawsuit over delayed entry of a generic version of its hypertension drug Traceer. Claims that Actelion denied generic drug makers...To view the full article, register now.
Already a subscriber? Click here to view full article